- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01860209
Effect of Intermittent Hemodialysis on Sleep Apnea Syndrome in End Stage Renal Disease Patients (SASinHD)
Effect of Intermittent Hemodialysis on Sleep Apnea Syndrome and Its Correlation to Nocturnal Rostral Fluid Shift, in End Stage Renal Disease Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
Obstructive sleep disordered breathing is more prevalent in end stage kidney disease patients than in the general population, and may participate to the increased cardiovascular mortality observed in this group of patients. Despite a significant increase in knowledge about the harmful effects of obstructive sleep apnea, the pathophysiological mechanisms are poorly understood. Recent observations suggest a causative relationship between overnight fluid displacement from the legs to the neck soft and the severity of obstructive sleep apnea. This mechanism was demonstrated in otherwise healthy subjects, in heart failure patients, and in patients with venous insufficiency. We thus suspect that this pathophysiologic mechanism could explain the increased prevalence of obstructive sleep apnea in patients with hypervolemia, including chronic renal failure.
The purpose of this trial is to investigate the hypothesis that nocturnal rostral fluid ship is linked to overhydration and participates significantly to the severity of obstructive sleep apnea in patients on hemodialysis. The correction of overhydration by hemodialysis should therefore reduce the amount of nocturnally displaced water and consequently lower the severity of obstructive sleep apnea.
The severity of obstructive sleep apnea is measured by two consecutive attended polysomnographies, performed before and after an ambulatory hemodialysis session with fluid removal, whereas overhydration and leg fluid are evaluated by bioimpedance, performed at the beginning and at the end of each polysomnography. The sequence of the two polysomnographies with respect to hemodialysis is randomized, to minimize the first-night effect.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1011
- Centre d'Investigation et Recherche sur le Sommeil (CIRS) - Centre Hospitalier Universitaire Vaudois (CHUV)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- moderate to severe obstructive sleep apnea syndrome, with an apnea-hypopnea index (AHI) ≥ 15/h
- age ≥ 18 years
- patient with end stage renal disease on chronic intermittent hemodialysis
Exclusion criteria:
- unstable congestive heart failure
- pace-maker
- active psychiatric disease
- amputation of the lower limbs, proximal to the ankle
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
the first polysomnography (PSG) is performed before hemodialysis (HD), followed by a post-HD PSG on the subsequent night
|
Intermittent ambulatory hemodialysis session, according to the patient usual protocol (defined by the treating nephrologist independently of the study)
|
|
Experimental: Group B
the first PSG is performed after hemodialysis (HD), followed by a pre-HD PSG, on the subsequent night
|
Intermittent ambulatory hemodialysis session, according to the patient usual protocol (defined by the treating nephrologist independently of the study)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of the obstructive sleep apnea severity
Time Frame: two nights (before and after an ambulatory hemodialysis session)
|
Reduction of the obstructive sleep apnea severity, measured by attended polysomnography, after an ambulatory hemodialysis session
|
two nights (before and after an ambulatory hemodialysis session)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in nocturnal leg fluid volume shift between the legs and the neck
Time Frame: two nights (before and after an ambulatory hemodialysis session)
|
Reduction in nocturnal leg fluid volume shift between the legs and the neck, measured by bioimpedance and neck circumference after an ambulatory hemodialysis session
|
two nights (before and after an ambulatory hemodialysis session)
|
|
relationship between overhydration, leg fluid volume shift, ankle and neck circumference and the severity of obstructive sleep apnea syndrome
Time Frame: one night
|
relationship between overhydration (measured by bioimpedance), leg fluid volume shift, ankle and neck circumference and the severity of obstructive sleep apnea syndrome
|
one night
|
|
severity of the periodic limb movement disorder (PLMD)
Time Frame: two nights (before and after one hemodialysis session)
|
severity of the periodic limb movement disorder (PLMD)
|
two nights (before and after one hemodialysis session)
|
|
severity of central sleep apnea syndrome
Time Frame: two nights (before and after one hemodialysis session)
|
severity of central sleep apnea syndrome
|
two nights (before and after one hemodialysis session)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Raphael Heinzer, MD, Centre d'Investigation et Recherche sur le Sommeil (CIRS) - Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Urologic Diseases
- Renal Insufficiency
- Signs and Symptoms, Respiratory
- Renal Insufficiency, Chronic
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Kidney Diseases
- Apnea
- Kidney Failure, Chronic
Other Study ID Numbers
- CIRS-SASinHD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
Isabel Moreno HayAmerican Academy of Dental Sleep MedicineRecruitingObstructive Sleep Apnea (SAOS) | Obstructive Sleep Apnea (OSAS)United States
-
Mayo ClinicEnrolling by invitationObstructive Sleep Apnea | OSA | Obstructive Sleep Apnea (OSA)United States
-
Mardin Artuklu UniversityNot yet recruitingObstructive Sleep Apnea | Sleep ApneaTurkey (Türkiye)
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); ResMed FoundationRecruitingObstructive Sleep Apnea | Sleep ApneaUnited States
-
Hospices Civils de LyonNot yet recruitingObstructive Sleep ApneaFrance
-
University Hospital, AntwerpNot yet recruiting
-
Nyxoah Inc.Not yet recruitingObstructive Sleep ApneaUnited States
-
Restera, Inc.RecruitingObstructive Sleep ApneaAustralia
Clinical Trials on Hemodialysis
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...European Renal Association - European Dialysis and Transplant AssociationRecruitingEnd Stage Renal Disease on DialysisItaly
-
Fundacion para la Investigacion Biomedica del Hospital...Completed
-
National Institute of Diabetes and Digestive and...Completed
-
Satellite HealthcareCompletedEnd Stage Renal Disease | Chronic Kidney DiseaseUnited States
-
Palo Alto Veterans Institute for ResearchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHemodialysis | Kidney Failure, ChronicUnited States
-
Sun Yat-sen UniversityCompletedHyperparathyroidism | Insomnia | Refractory Pruritus | OstalgiaChina
-
Xinhua Hospital, Shanghai Jiao Tong University...Changhai Hospital; Shanghai Zhongshan Hospital; RenJi Hospital; Ruijin Hospital; Shanghai... and other collaboratorsCompleted
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Unknown
-
Universita degli Studi di GenovaIRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale...CompletedCovid19 | Hemodialysis Complication | Inflammatory ResponseItaly
-
Unity Health TorontoHeart and Stroke Foundation of CanadaCompletedEnd-stage Renal Disease | Left Ventricular HypertrophyCanada